Litcius/Paper detail

BNT162b2 vaccine effectiveness against SARS-CoV-2 omicron BA.4 and BA.5

Sara Y. Tartof, Jeff Slezak, Laura Puzniak, Vennis Hong, Timothy B. Frankland, Bradley K. Ackerson, Harpreet S. Takhar, Oluwaseye Ayoola Ogun, Sarah Simmons, Joann M. Zamparo, Luis Jódar, John M. McLaughlin

2022The Lancet Infectious Diseases77 citationsDOIOpen Access PDF

Topics & Concepts

Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Virology2019-20 coronavirus outbreakBiologyMedicineOutbreakInfectious disease (medical specialty)DiseasePathologySARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studiesvaccines and immunoinformatics approaches
BNT162b2 vaccine effectiveness against SARS-CoV-2 omicron BA.4 and BA.5 | Litcius